INMD - InMode Ltd. Stock Analysis | Stock Taper
Logo

About InMode Ltd.

https://www.inmodemd.com

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.

Moshe Mizrahy

CEO

Moshe Mizrahy

Compensation Summary
(Year )

Total Compensation (Unknown At The Moment)
Industry Medical - Devices
Sector Healthcare
Went public August 8, 2019
Method of going public IPO
Full time employees 599

Split Record

Date Type Ratio
2021-10-01 Forward 2:1

ETFs Holding This Stock

Ratings Snapshot

Rating : S-

Discounted Cash Flow 5
Return On Equity 5
Return On Assets 5
Debt To Equity 4
Price To Earnings 3
Price To Book 4
Overall Score 5

Most Recent Analyst Grades

Grade Summary

Overweight 1
Neutral 2
Hold 3

Showing Top 6 of 6

Price Target

Target High $15
Target Low $15
Target Median $15
Target Consensus $15

Institutional Ownership

Summary

% Of Shares Owned 44.92%
Total Number Of Holders 248

Showing Top 3 of 248